title: [Anxiety disorders: long-term treatment and replapse prevention].
abstract: Anxiety disorders show a tendency to become chronic. Behavioral treatment and pharmacotherapeutic measures must frequently be applied over a lengthy period of time. The most suitable drugs for long-term treatment are the selective serotonin reuptake inhibitors (SSRI) and the serotonin norepinephrine reuptake inhibitor (SNRI), venlafaxine. With regard to side effects, the specific characteristics of the anti-anxiety drugs used for long-term therapy must be taken into account.
authors.affiliation: Klinik für Psychiatrie und Psychotherapie, Universität Göttingen. sekretariat.bandelow@medizin.uni-goettingen.de
authors.forename: Von B
authors.initials: VB
authors.lastname: Bandelow
authors.forename: C
authors.initials: C
authors.lastname: Wolff-Menzler
authors.forename: D
authors.initials: D
authors.lastname: Wedekind
authors.forename: E
authors.initials: E
authors.lastname: Rüther
mesh_terms: D014151:Anti-Anxiety Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology; D003131:Combined Modality Therapy; D006801:Humans; D008134:Long-Term Care; D016584:Panic Disorder / Q000188:drug therapy* / Q000523:psychology; D011379:Prognosis; D011613:Psychotherapy
chemical_list: D014151:Anti-Anxiety Agents